Benzinga

Benzinga

Benzinga

miércoles, agosto 19

Lyell Immunopharma Inc

LYELNASDAQ
Trade with Public
Trade with Public
$15.79
2.2416.53%
al cierre: Aug 18, 5:00 PM EST
$15.48
-0.31-1.96%
After hour: 7:57 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Lyell Immunopharma Financials

Lyell Immunopharma (LYEL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Lyell Immunopharma Q1 EPS $(1.10) Beats $(2.19) Estimate, Sales $2.000K Miss $4.400K Estimate

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(1.10) per share which beat the analyst consensus estimate of $(2.19) by 49.77 percent. This is a 69.44 percent increase over losses of $(3.60) per share
Benzinga Newsdesk

PRO
Lyell Immunopharma Q4 EPS $(7.68) Misses $(2.55) Estimate, Sales $6.000K Miss $20.330K Estimate

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(7.68) per share which missed the analyst consensus estimate of $(2.55) by 201.18 percent. This is a 140 percent decrease over losses of $(3.20) per share
Benzinga Newsdesk

PRO
Lyell Immunopharma Q3 Sales $15.000K Down From $34.000K YoY

Benzinga Newsdesk

PRO
Lyell Immunopharma Q2 EPS $(2.89) Beats $(3.82) Estimate, Sales $8.000K Down From $13.000K YoY

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(2.89) per share which beat the analyst consensus estimate of $(3.82) by 24.4 percent. This is a 19.5 percent increase over losses of $(3.59) per share from
Benzinga Newsdesk

PRO
Lyell Immunopharma Q1 EPS $(0.18) Beats $(0.20) Estimate, Sales $7.00K Up From $3.00K YoY

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 25 percent increase over losses of $(0.24) per share from the
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved